Insider · CIK 0001619009
Jeffrey M Rowe
Files at ZOMDF (Zomedica Corp.). First filing -, latest -.
In brief
Jeffrey M Rowe files SEC Form 4 as director at ZOMDF (Zomedica Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeffrey M Rowe has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | ZOMDF Zomedica Corp. | AGrant or award Stock Appreciation Rightderivative | +2,126,959 | $0.00 | $0 | 2,126,959 | Nov 18, 2025 |
| Nov 11, 2024 | ZOMDF Zomedica Corp. | AGrant or award Stock Appreciation Rightsderivative | +2,126,959 | $0.00 | $0 | 2,126,959 | Nov 13, 2024 |
Questions about Jeffrey M Rowe
Answered from the filings on this page, as of the latest one.
Is Jeffrey M Rowe buying or selling?
Jeffrey M Rowe has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeffrey M Rowe's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey M Rowe has 0.
Where does Jeffrey M Rowe file Form 4?
Jeffrey M Rowe has filed Form 4 at ZOMDF (Zomedica Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.